학술논문

Deterministic reprogramming and signaling activation following targeted therapy in non-small cell lung cancer driven by mutations or oncogenic fusions
Document Type
Article
Source
In: Expert Opinion on Investigational Drugs. (Expert Opinion on Investigational Drugs, 2024, 33(3):171-182)
Subject
Language
English
ISSN
17447658
13543784